FluMist Home offers at-home, needle-free flu vaccination

A new at‑home option for flu vaccination is now available, offering a needle-free alternative that can be administered from a shopper’s living room. FluMist Home, a nasal spray version of the flu vaccine made by AstraZeneca, is being sold online and is designed for self‑administration or administration by an adult to children. Eligible individuals in most cases are adults under 50 for self‑use and adults can help children aged 2 to 17. The service requires a screening by a licensed professional prior to shipment, and shipments must be kept cold to maintain effectiveness. The rollout comes as health officials seek to make vaccination more convenient and address ongoing declines in flu vaccination rates.

The nasal spray works differently from a traditional flu shot. It uses a live, weakened form of the virus that is adapted to survive only in the nose, where it prompts the immune system to produce antibodies. While the vaccine is a live virus, it is not intended to cause illness, and most people experience only minor, short‑lived side effects such as a runny nose, congestion, sore throat, or fever. Experts emphasize that, as with all vaccines, effectiveness depends in part on how...